<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.03679.006</object-id><label>Table 1.</label><caption><p>Mutation type distribution in MNV populations treated with ribavirin and favipiravir</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.03679.006">http://dx.doi.org/10.7554/eLife.03679.006</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="2">Untreated</th><th colspan="2">Ribavirin</th><th colspan="2">Favipiravir</th></tr><tr><th/><th>MNV-1</th><th>MNV-3</th><th>MNV-1</th><th>MNV-3</th><th>MNV-1</th><th>MNV-3</th></tr></thead><tbody><tr><td>A &#8594; G</td><td>4</td><td>4</td><td>1</td><td>3</td><td>9</td><td>5</td></tr><tr><td>U &#8594; C</td><td>1</td><td>3</td><td>1</td><td>2</td><td>3</td><td>7</td></tr><tr><td>G &#8594; A</td><td>0</td><td>2</td><td>5</td><td>2</td><td>2</td><td>0</td></tr><tr><td>C &#8594; U</td><td>4</td><td>1</td><td>4</td><td>4</td><td>0</td><td>4</td></tr><tr><td>Transversions</td><td>1</td><td>3</td><td>1</td><td>2</td><td>1</td><td>0</td></tr><tr><td>Deletions</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td></tr><tr><td>Total nucleotides sequenced<xref ref-type="table-fn" rid="tblfn1">*</xref></td><td>63,395</td><td>65,822</td><td>23,358</td><td>20,243</td><td>12,488</td><td>16,003</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>*</label><p>Total number of nucleotides sequenced in each different untreated or treated population analysed.</p></fn><fn><p>Proportion of different types of mutations observed in untreated, or ribavirin- or favipiravir-treated MNV populations.</p></fn></table-wrap-foot></table-wrap>